Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sakura Italia is an Italian pharmaceutical and medical device company specializing in the development and commercialization of products for gynecology, urology, and proctology. Founded in 2004 and headquartered in Lonato del Garda, the company offers a diverse portfolio including nutraceuticals and topical medical devices designed to improve patient quality of life. In 2017, Sakura Italia was acquired by the Italfarmaco Group, a move that strengthened its market position and expanded its reach within the Italian healthcare sector. The company is well-known for brands such as Anonet, Kistinox, and Santes, which address common conditions like urinary tract infections and anorectal disorders. Its business model relies heavily on a dedicated network of medical representatives who provide scientific information to specialist physicians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sakura Italia.